ORIGINAL RESEARCH
Accepted on 05 Feb 2026
- Frontiers in Endocrinology
- Clinical Diabetes
- Research Topics
- Future Horizons in Diabetes: Integrating Gut Microbiota, AI, and Personalized Care
Future Horizons in Diabetes: Integrating Gut Microbiota, AI, and Personalized Care
5,002
Total downloads
30k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Accepted on 29 Jan 2026
Endoplasmic Reticulum Stress in Skeletal Muscle Dysfunction of Type 2 Diabetes: Mechanisms and Therapeutic Implications
- 180 views
ORIGINAL RESEARCH
Published on 03 Dec 2025
Association of serum miR-99a level and metabolic dysfunction-associated steatotic liver disease, serum mTOR levels in patients with type 2 diabetes mellitus
doi 10.3389/fendo.2025.1724108
- 949 views
ORIGINAL RESEARCH
Published on 01 Dec 2025
The intestinal microbiota of patients with type 2 diabetes is associated with the C-512T polymorphism of the FOXC2 gene
doi 10.3389/fendo.2025.1674135
- 680 views
MINI REVIEW
Published on 03 Nov 2025
Integrating gut microbiota into multidisciplinary perspectives on diabetic neuropathy
doi 10.3389/fendo.2025.1710868
- 1,549 views
REVIEW
Published on 03 Nov 2025
Harnessing gut-derived bioactives and AI diagnostics for the next generation of type 2 diabetes solutions
doi 10.3389/fendo.2025.1699954
- 2,804 views
BRIEF RESEARCH REPORT
Published on 25 Sep 2025
Microcirculatory disturbances in type 2 diabetes: early detection using laser doppler flowmetry for personalized care
doi 10.3389/fendo.2025.1651525
- 1,308 views
ORIGINAL RESEARCH
Published on 18 Sep 2025
Future horizons in diabetes treatment: hypoglycemic activity of [1,2,4]triazino[2,3-c]quinazoline derivatives
doi 10.3389/fendo.2025.1638013
- 1,955 views
- 2 citations
SYSTEMATIC REVIEW
Published on 09 Jul 2025
Data mining–based analysis to explore the application of an animal model of diabetic gastroparesis
doi 10.3389/fendo.2025.1612473
- 2,577 views
CLINICAL TRIAL
Published on 06 May 2025
Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial
doi 10.3389/fendo.2025.1575087
- 3,741 views
- 3 citations
PERSPECTIVE
Published on 27 Mar 2025
Future horizons in diabetes: integrating AI and personalized care
doi 10.3389/fendo.2025.1583227
- 8,866 views
- 12 citations
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: